Phenotype measures set:   Wiltshire3   SLC6A2

ID, description, units MPD:38179   SLC6A2   cerebral cortex SLC6A2 (NET), relative fluorescence intensity  
fluoxetine study
Measures • control    • fluoxetine    • change index
Data set, strains Wiltshire3   inbred   30 strains     sex: m     age: 10-11wks
Procedure biomarker quantification
Comparisoncontrol group vs. treated group
Availability note:Individual animal data were not submitted. Some functionality not available.
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Wiltshire3 - cerebral cortex SLC6A2 (NET), relative fluorescence intensity







  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelStrains
tested
SexAge
Wiltshire3 38179 biomarker quantification fluoxetine cerebral cortex SLC6A2 (NET), relative fluorescence intensity   control   SLC6A2_cont inbred 30 m 10-11wks
Wiltshire3 38180 biomarker quantification fluoxetine cerebral cortex SLC6A2 (NET), relative fluorescence intensity   fluoxetine   SLC6A2_fluox inbred 30 m 10-11wks
Wiltshire3 38181 biomarker quantification fluoxetine cerebral cortex SLC6A2 (NET), relative fluorescence intensity   change index   SLC6A2_index inbred 30 m 10-11wks (supplemental /
  summary measure)